622 related articles for article (PubMed ID: 30466671)
1. Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.
Yadlapati R; DeLay K
Med Clin North Am; 2019 Jan; 103(1):15-27. PubMed ID: 30466671
[TBL] [Abstract][Full Text] [Related]
2. Review of antireflux procedures for proton pump inhibitor nonresponsive gastroesophageal reflux disease.
Hillman L; Yadlapati R; Whitsett M; Thuluvath AJ; Berendsen MA; Pandolfino JE
Dis Esophagus; 2017 Sep; 30(9):1-14. PubMed ID: 28859357
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of the RefluxStop device for management of refractory gastroesophageal reflux disease in Switzerland.
Harper S; Kartha M; Mealing S; Borbély YM; Zehetner J
J Med Econ; 2024; 27(1):805-815. PubMed ID: 38820006
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitor-refractory gastroesophageal reflux disease: current diagnosis and management.
Frazzoni L; Fuccio L; Frazzoni M
Minerva Gastroenterol Dietol; 2017 Sep; 63(3):249-256. PubMed ID: 28251845
[TBL] [Abstract][Full Text] [Related]
5. Endotherapy for and tailored approaches to treating GERD, and refractory GERD.
Locke GR; Horwhat J; Mashimo H; Savarino E; Zentilin P; Savarino V; Zerbib F; Armbruster SP; Wong RK; Moawad F
Ann N Y Acad Sci; 2013 Oct; 1300():166-186. PubMed ID: 24117641
[TBL] [Abstract][Full Text] [Related]
6. Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel.
Yadlapati R; Vaezi MF; Vela MF; Spechler SJ; Shaheen NJ; Richter J; Lacy BE; Katzka D; Katz PO; Kahrilas PJ; Gyawali PC; Gerson L; Fass R; Castell DO; Craft J; Hillman L; Pandolfino JE
Am J Gastroenterol; 2018 Jul; 113(7):980-986. PubMed ID: 29686276
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
[TBL] [Abstract][Full Text] [Related]
8. Association between CYP2C19 extensive metabolizer phenotype and childhood anti-reflux surgery following failed proton pump inhibitor medication treatment.
Franciosi JP; Mougey EB; Williams A; Gomez Suarez RA; Thomas C; Creech CL; George K; Corao D; Lima JJ
Eur J Pediatr; 2018 Jan; 177(1):69-77. PubMed ID: 29209919
[TBL] [Abstract][Full Text] [Related]
9. LINX
Skubleny D; Switzer NJ; Dang J; Gill RS; Shi X; de Gara C; Birch DW; Wong C; Hutter MM; Karmali S
Surg Endosc; 2017 Aug; 31(8):3078-3084. PubMed ID: 27981382
[TBL] [Abstract][Full Text] [Related]
10. The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients.
Rinsma NF; Farré R; Bouvy ND; Masclee AA; Conchillo JM
Neurogastroenterol Motil; 2015 Feb; 27(2):220-8. PubMed ID: 25348594
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic management of gastroesophageal reflux disease: Panacea for proton pump inhibitors dependent/refractory patients.
Kalapala R; Singla N; Reddy DN
Dig Endosc; 2022 May; 34(4):687-699. PubMed ID: 34651353
[TBL] [Abstract][Full Text] [Related]
12. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
Azzam RS
Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of refractory gastroesophageal reflux disease (GERD) symptoms -is switching proton pump inhibitors based on the patient's CYP2C19 genotype an effective management strategy?
Takeuchi T; Oota K; Harada S; Edogawa S; Kojima Y; Sanomura M; Sakaguchi M; Hayashi K; Hongoh Y; Itabashi T; Kitae H; Hoshimoto M; Takeuchi N; Higuchi K
Intern Med; 2015; 54(2):97-105. PubMed ID: 25742999
[TBL] [Abstract][Full Text] [Related]
14. A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease.
Hillman L; Yadlapati R; Thuluvath AJ; Berendsen MA; Pandolfino JE
Dis Esophagus; 2017 Sep; 30(9):1-15. PubMed ID: 28859358
[TBL] [Abstract][Full Text] [Related]
15. A novel endoscopic submucosal dissection technique for proton pump inhibitor-refractory gastroesophageal reflux disease.
Ota K; Takeuchi T; Harada S; Edogawa S; Kojima Y; Inoue T; Higuchi K
Scand J Gastroenterol; 2014 Dec; 49(12):1409-13. PubMed ID: 25384555
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic treatment of proton pump inhibitor-refractory gastroesophageal reflux disease with anti-reflux mucosectomy: Experience of 109 cases.
Sumi K; Inoue H; Kobayashi Y; Iwaya Y; Abad MRA; Fujiyoshi Y; Shimamura Y; Ikeda H; Onimaru M
Dig Endosc; 2021 Mar; 33(3):347-354. PubMed ID: 32415898
[TBL] [Abstract][Full Text] [Related]
17. New treatment method for refractory gastroesophageal reflux disease (GERD): C-BLART (clip band ligation anti-reflux therapy)-a short-term study.
Liu S; Chai N; Zhai Y; Zou J; Feng X; Li Z; Li L; Zhang X; Wang X; Wang S; Linghu EQ
Surg Endosc; 2020 Oct; 34(10):4516-4524. PubMed ID: 31728750
[TBL] [Abstract][Full Text] [Related]
18. Comparative Analysis of Laparoscopic Fundoplication and Magnetic Sphincter Augmentation for the Treatment of Medically Refractory GERD.
Richards WO; McRae C
Am Surg; 2018 Nov; 84(11):1762-1767. PubMed ID: 30747630
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Vonoprazan for Gastroesophageal Reflux Symptoms in Patients with Proton Pump Inhibitor-resistant Non-erosive Reflux Disease.
Niikura R; Yamada A; Hirata Y; Hayakawa Y; Takahashi A; Shinozaki T; Takeuchi Y; Fujishiro M; Koike K
Intern Med; 2018 Sep; 57(17):2443-2450. PubMed ID: 29607951
[TBL] [Abstract][Full Text] [Related]
20. Management of gastro-oesophageal reflux disease symptoms that do not respond to proton pump inhibitors.
Woodland P; Sifrim D
Curr Opin Gastroenterol; 2013 Jul; 29(4):431-6. PubMed ID: 23549342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
